Magneto-Electric Nanoparticles for Targeted Cell Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for targeting cancer cells with nanoparticles are limited by the reliance on ligands or antibodies matching cancer cells, and the Enhanced Permeability and Retention (EPR) effect, which may not accumulate enough nano-particles for effective treatment, while also lacking effective methods for killing viruses and antibiotic-resistant bacteria.
Innovation Solution
The use of Magneto-Electric Nano-Particles (MENPs) that are administered and subjected to a magnetic field to generate an electric field, allowing for targeted accumulation at less negatively charged cells, such as cancer cells, and for delivering drugs or disrupting bacterial and viral functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ligands or antibodies are used to target cancer cells, then specificity to cancer cells is improved, but availability of matching ligands or antibodies is limited
Solution Approach 1:
The patent replaces the biochemical targeting mechanism (ligands/antibodies binding to receptors) with a physical field-based mechanism. Magneto-electric nanoparticles respond to external electromagnetic fields, allowing targeting through field application rather than molecular recognition. This substitutes a mechanical/physical system for the biochemical system, enabling broader adaptability while maintaining cancer cell specificity through field-controlled accumulation.
Solution Approach 2:
The patent changes the fundamental parameter of nanoparticle targeting from chemical specificity (ligand-receptor matching) to physical responsiveness (magneto-electric properties). By using nanoparticles with specific magneto-electric parameters that respond to external fields, the system achieves cancer cell targeting through physical parameter differences between tumor and normal tissues, expanding versatility beyond available biological ligands.
2Quantity of substance
If EPR effect is used to accumulate nanoparticles, then accumulation at cancer site is improved, but enough nanoparticles cannot be accumulated for effective treatment
Solution Approach 1:
The patent applies external electromagnetic fields before and during nanoparticle administration to pre-condition the cancer site for nanoparticle accumulation. The fields are applied in advance to create favorable conditions for nanoparticle uptake and retention, ensuring sufficient accumulation reaches therapeutic thresholds. This preliminary field application overcomes the limitation of passive EPR effect by actively preparing the target site.
Solution Approach 2:
The patent introduces external electromagnetic fields as an intermediary mechanism to enhance nanoparticle accumulation. The fields act as a mediator between the nanoparticles and cancer cells, facilitating increased uptake and retention beyond what passive EPR effect alone can achieve. This intermediary field mechanism bridges the gap between nanoparticle administration and sufficient therapeutic accumulation.
3Use of energy by moving object
If point contact electrodes are used for electrical stimulation, then electrical stimulation is applied, but uniform stimulation at cellular levels cannot be achieved
Solution Approach 1:
The patent segments the electrical stimulation delivery by using numerous small magneto-electric nanoparticles distributed throughout the tissue rather than a single point contact electrode. Each nanoparticle acts as a discrete stimulation source, and their collective distribution creates uniform cellular-level stimulation. This segmentation of the stimulation field resolves the non-uniformity problem inherent in point contact methods.
Solution Approach 2:
The patent transitions from one-dimensional point contact stimulation to three-dimensional distributed nanoparticle stimulation. By dispersing nanoparticles throughout the tissue volume and activating them with external fields, the system achieves uniform stimulation across multiple spatial dimensions at the cellular level, overcoming the limitations of surface-level point contact electrodes.
4Quantity of substance
If large nanoparticles are used, then EPR effect can accumulate them, but they are limited to relatively large nanoparticle sizes
Solution Approach 1:
The patent creates a universal nanoparticle platform with magneto-electric properties that functions across a broad size range. These nanoparticles can be accumulated through field application regardless of whether they are small or large, making the system universally applicable to different nanoparticle sizes. This multi-functionality allows the same mechanism to work for various size classes, overcoming the size limitation of EPR effect.
Solution Approach 2:
The patent changes the accumulation mechanism from size-dependent passive EPR effect to field-responsive active accumulation. By using external electromagnetic fields to drive nanoparticle accumulation, the system decouples accumulation efficiency from nanoparticle size, allowing effective accumulation of nanoparticles across a wide size range including smaller particles that cannot benefit from EPR effect.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the specificity and accumulation of nanoparticles at cancer sites, enables effective stimulation of skin cells for cosmetic benefits, and provides a method for killing bacteria and viruses with minimal harm to normal cells.
Implementation Method 1
applying a magnetic field to the MENPs to generate an electric field
Data Source
AI summary
This invention presents methods for targeting and killing types of cells or organisms using Magneto-Electric Nano-Particles under the control of an external magnetic field. A method was also presented for using Magneto-Electric Nano-Particles to stimulate or rejuvenate cells under an external magnetic field.